LifeStance Health Group Statistics
Share Statistics
LifeStance Health Group has 382.64M shares outstanding. The number of shares has increased by 0.51% in one year.
| Shares Outstanding | 382.64M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 111.01M |
| Failed to Deliver (FTD) Shares | 2.62K |
| FTD / Avg. Volume | 0.18% |
Short Selling Information
The latest short interest is 10.97M, so 2.87% of the outstanding shares have been sold short.
| Short Interest | 10.97M |
| Short % of Shares Out | 2.87% |
| Short % of Float | 9.88% |
| Short Ratio (days to cover) | 6.6 |
Valuation Ratios
The PE ratio is -15.45 and the forward PE ratio is -43.53.
| PE Ratio | -15.45 |
| Forward PE | -43.53 |
| PS Ratio | 2.73 |
| Forward PS | 1.9 |
| PB Ratio | 2.01 |
| P/FCF Ratio | -50.12 |
| PEG Ratio | n/a |
Enterprise Valuation
LifeStance Health Group Inc. has an Enterprise Value (EV) of 3.31B.
| EV / Earnings | -17.77 |
| EV / Sales | 3.13 |
| EV / EBITDA | -31.54 |
| EV / EBIT | -17.5 |
| EV / FCF | -57.65 |
Financial Position
The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.2.
| Current Ratio | 1.11 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.2 |
| Total Debt / Capitalization | 16.54 |
| Cash Flow / Debt | -0.06 |
| Interest Coverage | -8.91 |
Financial Efficiency
Return on equity (ROE) is -0.13% and return on capital (ROIC) is -8.79%.
| Return on Equity (ROE) | -0.13% |
| Return on Assets (ROA) | -0.08% |
| Return on Capital (ROIC) | -8.79% |
| Revenue Per Employee | 145.23K |
| Profits Per Employee | -25.62K |
| Employee Count | 7.27K |
| Asset Turnover | 0.47 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | -20.32M |
| Effective Tax Rate | 0.1 |
Stock Price Statistics
The stock price has increased by 13.14% in the last 52 weeks. The beta is 1.24, so LifeStance Health Group 's price volatility has been higher than the market average.
| Beta | 1.24 |
| 52-Week Price Change | 13.14% |
| 50-Day Moving Average | 7.35 |
| 200-Day Moving Average | 6.46 |
| Relative Strength Index (RSI) | 58.9 |
| Average Volume (20 Days) | 1.49M |
Income Statement
In the last 12 months, LifeStance Health Group had revenue of 1.06B and earned -186.26M in profits. Earnings per share was -0.51.
| Revenue | 1.06B |
| Gross Profit | 302.10M |
| Operating Income | -189.13M |
| Net Income | -186.26M |
| EBITDA | -104.93M |
| EBIT | -189.13M |
| Earnings Per Share (EPS) | -0.51 |
Balance Sheet
The company has 78.82M in cash and 511.04M in debt, giving a net cash position of -432.22M.
| Cash & Cash Equivalents | 78.82M |
| Total Debt | 511.04M |
| Net Cash | -432.22M |
| Retained Earnings | -760.85M |
| Total Assets | 2.11B |
| Working Capital | 69.51M |
Cash Flow
In the last 12 months, operating cash flow was -16.88M and capital expenditures -40.52M, giving a free cash flow of -57.40M.
| Operating Cash Flow | -16.88M |
| Capital Expenditures | -40.52M |
| Free Cash Flow | -57.40M |
| FCF Per Share | -0.16 |
Margins
Gross margin is 28.62%, with operating and profit margins of -17.92% and -17.64%.
| Gross Margin | 28.62% |
| Operating Margin | -17.92% |
| Pretax Margin | -19.57% |
| Profit Margin | -17.64% |
| EBITDA Margin | -9.94% |
| EBIT Margin | -17.92% |
| FCF Margin | -5.44% |
Dividends & Yields
LFST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -6.58% |
| FCF Yield | -1.94% |
Analyst Forecast
The average price target for LFST is $9, which is 16.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $9 |
| Price Target Difference | 16.1% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
Scores
| Altman Z-Score | 2.59 |
| Piotroski F-Score | 5 |